Anti-viral immunity against Marek's disease virus infected chicken kidney cells

Area of Science:

• Veterinary Immunology
• Avian Pathology
• Cellular Immunology

Background:

• Marek's disease (MD) is a significant lymphoproliferative disease in chickens.
• Herpesvirus of turkeys (HVT) is widely used as a vaccine against MDV.
• The precise immunological mechanisms underlying HVT-induced protection against MDV remain under investigation.

Purpose of the Study:

• To elucidate the immunological mechanisms of immunity conferred by HVT vaccination against Marek's disease virus (MDV).
• To investigate the role of cellular cytotoxicity in HVT-mediated protection.

Main Methods:

• Utilized Marek's disease virus (MDV)-infected chicken kidney cell (CKC) cultures as target cells.
• Assessed the cytotoxic activity of peripheral blood lymphocytes (PBL) from normal, HVT-vaccinated, and MDV-inoculated chickens.
• Evaluated the effect of anti-MDV and anti-HVT serum on cellular cytotoxicity.

Main Results:

• PBL from HVT-vaccinated chickens demonstrated specific cytotoxic effects against HVT-infected CKC.
• PBL from chickens inoculated with MDV showed specific cytotoxicity against MDV-infected CKC.
• Cytotoxicity against MDV-infected target cells was enhanced in the presence of specific antibodies (anti-MDV or anti-HVT).

Conclusions:

• Antibody-dependent cellular cytotoxicity (ADCC) against MDV-infected cells may be a key mechanism contributing to Marek's disease resistance following HVT vaccination.
• Cell-mediated immunity plays a specific role in response to both HVT and MDV infections.
• HVT vaccination likely primes an immune response that includes ADCC, offering protection against MDV.